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Summary 
 
 A total of 59 gilts were used to determine 
the effects of supplemental L-carnitine on gilt 
growth and maternal insulin-like growth fac-
tor-I (IGF-I).  Experimental treatments were 
arranged in a 2 × 3 factorial with main effects 
of L-carnitine (0 or 50 ppm) and day of gesta-
tion (40, 55, or 70).  All gilts received a con-
stant feed allowance of 3.86 lb/day and a top-
dress containing either 0 or 88 mg of L-
carnitine, starting on the first day of breeding.  
No differences (P>0.05) between treatments 
were observed for BW, estimated protein 
mass, or estimated fat mass at any gestation 
length.  At d 70 of gestation, there was a nu-
meric increase (P>0.10) in BW for the gilts 
fed L-carnitine, compared with those fed the 
control diet.  At d 40 of gestation, gilts fed L-
carnitine tended to have greater (P = 0.10) 
backfat, compared with the gilts fed the con-
trol diet; but no differences (P>0.05) were ob-
served in backfat on d 0, 55, or 70 of gesta-
tion.  In addition, no differences (P>0.05) 
were observed in maternal IGF-I between 
treatments at any gestation length.  Total and 
free plasma L-carnitine concentrations were 
similar (P>0.10) at d 0 of gestation, but con-
centrations were higher (P<0.01) by d 40 of 
gestation in the gilts fed L-carnitine.  These 
results show that supplemental L-carnitine 
numerically increases BW of gestating gilts.  
This data represents the first part of an ongo-
ing study, with the rest of the data being re-
ported in subsequent publications. 
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Introduction 
 
 L-carnitine is a vitamin-like, water-soluble 
quaternary amine that is a derivative of the 
amino acids lysine and methionine.  It is found 
in tissues such as the liver, kidney, brain, 
heart, and skeletal muscle, which can use fatty 
acids as an energy source.  The primary role 
of L-carnitine is to facilitate transport of long-
chain fatty acyl groups to the mitochondrial 
matrix for β-oxidation for cellular energy pro-
duction.  In addition, L-carnitine increases 
glucose disposal and carbohydrate oxidation 
rate, therefore playing a role in carbohydrate 
metabolism.  
  
 Research has demonstrated that supple-
menting sow’s diets with L-carnitine during 
gestation improves reproductive performance.  
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L-carnitine supplementation during gestation 
increased sow BW gain, and last-rib backfat, 
and in some studies has been shown to in-
crease circulating IGF-I.  In addition, supple-
mental L-carnitine in a sow’s diet increased 
pig and litter weight at birth, reduced the 
number of stillborn pigs, and increased litter 
size.  
 
 To our knowledge, two research groups 
have studied the effect of L-carnitine supple-
mentation on performance parameters in gilts.  
The addition of dietary L-carnitine to gesta-
tion diets has not shown consistent perform-
ance on first-parity reproductive performance.  
Therefore, our objective in this study was to 
determine the effects of supplementing with 
L-carnitine through the developmental stages 
of gestation.  We examined gilt weight, back-
fat, circulating IGF-I, and free and total L-
carnitine at d 0, 40, 55, and 70 of gestation.   
 
 This experiment is part of a large, com-
prehensive study designed to evaluate the ef-
fects of L-carnitine on gilt reproductive per-
formance, the IGF system in maternal tissues, 
fetal traits such as IGF gene expression in fe-
tal myoblasts, and fetal muscle cell prolifera-
tion and differentiation.  
 
Procedures 
 
 Animals and Feeding Protocol.  All ani-
mal procedures used in this study were re-
viewed and approved by the Kansas State 
University Animal Care and Use Committee.  
Fifty-nine terminal gilts (PIC, Franklin, KY; 
L327 × 1050; BW = 303.6 lb) were artificially 
inseminated (PIC; MQ 280) 12, 24, and 36 h 
after the onset of the second observed estrus.  
Gilts were housed in individual gestation 
crates (7 ft × 22 in) in an environmentally 
controlled gestation barn at the Kansas State 
University Swine Teaching and Research Cen-
ter.  Gilts were allowed ad libitum access to 
water, and were randomly allotted to one of 
two dietary treatments and one of three har-
vesting dates (d 40, 55, or 70 of gestation) on 
the basis of weight at breeding.  All gilts were 
fed a corn-soybean meal gestation diet (Table 
1) once daily (3.86 lb/day), and received a  
50 g top-dress containing either none (control, 
n = 30) or 88 mg (equivalent to approximately 
50 ppm on an as-fed basis) of L-carnitine 
(Carniking 10 (10% of L-carnitine), n = 29; 
Lonza, Inc., Allendale, NJ) from d 1 until d 
39, 54, or 69 of gestation.  Last-rib backfat 
and weight were determined at breeding and at 
d 39, 54, and 69 of gestation.  Blood was col-
lected by veni-puncture 6 hr after feeding, for 
determination of circulating IGF-I and free 
and total L-carnitine, at d 0, 39, 54, and 69 of 
gestation.   
 
Table 1.  Diet Composition Fed During Gesta-
tiona 
Item  Gestation Diet 
Ingredient, %   
   Corn  81.22 
   Soybean meal (46.5% CP)  14.55 
   Monocalcium P (21% P)  2.03 
   Limestone  1.05 
   Salt  0.50 
   Vitamin premix  0.25 
   Trace mineral premix  0.15 
   Sow add pack  0.25 
Total  100.00 
 
Calculated analysis   
   Lysine, %  0.65 
   ME, kcal/lb  1,483 
   Protein, %  13.7 
   Ca, %  0.85 
   P, %  0.75 
   Available P, %  0.48 
aGestation feeding of 3.86 lb/d, with or with-
out a top-dress providing 88 mg/d (equivalent 
to 50 ppm on an as-fed basis) added L-
carnitine. 
 
 Statistical Analysis.  Backfat, weight, and 
maternal blood concentrations of L-carnitine 
and IGF-I were compared by using the 
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MIXED procedure of SAS.  Data were ana-
lyzed as repeated measures to include only the 
gilts harvested at d 70 of gestation (control,  
n = 10; L-carnitine, n = 10).  The model in-
cluded treatment as the fixed effect and day of 
sampling as the repeated measure.  The Ken-
ward-Roger adjustment was used to calculate 
the degrees of freedom.  Significance was de-
clared at P<0.05 unless otherwise noted.   
 
Results and Discussion 
 
 No differences (P>0.05) between treat-
ments were observed for BW, estimated pro-
tein mass, and estimated fat mass at any gesta-
tion length, although day of sampling was sig-
nificant for these response criteria (Table 2; 
P<0.0001).  At d 70 of gestation, there was a 
numerical increase (P = 0.43) in BW for the 
gilts fed L-carnitine, compared with that of 
gilts fed the control diet (L-carnitine = 375.5 
lb vs. control = 366.6 lb).  At d 40 of gesta-
tion, gilts fed L-carnitine tended to have 
greater (P = 0.10) backfat than did the gilts 
fed the control diet (L-carnitine = 17.9 mm vs. 
control = 16.3 mm), but no differences 
(P>0.05) were observed in backfat on day 0, 
55, or 70 of gestation between dietary treat-
ments.  Backfat increased for gilts fed dietary 
treatments from d 0 to 55 gestation, but then 
decreased from d 55 to d 70 of gestation. 
 
 Maternal IGF-I concentrations decreased 
(P<0.0001) from d 0 to 70 of gestation for the 
gilts fed supplemental L-carnitine and those 
fed the control diet (Figure 1).  No differences 
(P>0.05) were observed for maternal IGF-I 
collected at d 0, 40, 55, or 70 of gestation be-
tween the two treatments.  No differences 
(P>0.05) were observed in total and free L-
carnitine between the gilts fed L-carnitine and 
those fed the control diet at d 0 of gestation.  
Plasma total and free L-carnitine increased 
(P<0.0001) on d 40, 55, and 70 of gestation 
for gilts fed the L-carnitine top-dress (Figures 
2 and 3).  
 Results of this study show that supplemen-
tal L-carnitine numerically increased gilt BW 
at d 70 of gestation, without a significant 
change in backfat.  The underlying biochemi-
cal mechanisms are not clear, but the same 
trends have been observed in previous studies.  
One function of L-carnitine is to transport 
fatty acids to the inner mitochondrial mem-
brane for β-oxidation, perhaps sparing more 
amino acids for protein deposition or provid-
ing additional energy to be used for intrauter-
ine nutrient supply.   
 
 Previous research has shown that provid-
ing supplemental L-carnitine to sows in-
creased circulating IGF-I.  Pigs from the litters 
of these sows were heavier at birth.  The role 
of IGF-I in normal growth and development 
has been well documented, and it plays an im-
portant role in muscle cell proliferation.  Thus, 
the elevated levels of IGF-I may have im-
proved muscling in these pigs.  In contrast, 
other researchers have found no changes in 
circulating IGF-I in sows fed L-carnitine, 
when determined at d 55 of gestation, even 
though the litters from sows fed the L-
carnitine were heavier.  These researchers 
suggested that the heavier litter weights from 
sows fed L-carnitine were not due to increased 
maternal IGF-I.  The results of the current 
study suggest that circulating IGF-I is similar 
for gilts fed supplemental L-carnitine and gilts 
fed diets without supplemental L-carnitine.   
 
 In conclusion, providing supplemental L-
carnitine to gestating gilts increased maternal 
circulating total and free L-carnitine at each 
gestation day. This is beneficial because L-
carnitine plays a role in protein synthesis, glu-
cose homeostasis, and β-oxidation. At d 70 of 
gestation, L-carnitine supplementation re-
sulted in numerically increased gilt BW.  As 
gestation progressed, IGF-I decreased, but no 
treatment differences were observed in mater-
nal IGF-I at any gestation length.  Therefore, 
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any treatment differences in reproductive pa-
rameters may not be due to maternal IGF-I.  
 
 This experiment is one part of a large, 
comprehensive study designed to evaluate the 
effects of L-carnitine on litter characteristics 
such as weight, fetus number, and the IGF 
system.  Also, the IGF system in tissues from 
the gilt placenta and the endometrium and 
myometrium from the gilt uterus will be ex-
amined to determine the effects of supplemen-
tal L-carnitine.  Last, we will examine the ef-
fects of L-carnitine on IGF gene expression in 
fetal myoblasts and its effects on fetal muscle 
cell proliferation and differentiation.  
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Figure 3.  The Influence of Feeding Gilts L-carnitine on Circulating Total Carnitine. 
Figure 2.  The Influence of Feeding L-carnitine to Gilts on Circulating Free Carnitine. 
Figure 1.  The Influence of Feeding Gilts L-carnitine on Serum IGF-I Concentrations. 
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Table 2.  Effects of L-carnitine on Gilt Growth Characteristicsa 
     Probability, P < 
Item  Control  L-carnitine   Treatment    SE 
No. of Gilts  10   10        
Weight, lb             
   d 0  300.9   298.8   0.86    11.20 
   d 40   331.8   340.0   0.47    11.20 
   d 55  349.4   358.2   0.44    11.20 
   d 70  366.6   375.5   0.43    11.20 
Estimated protein mass, lbb            
   d 0  50.8   50.3   0.82    2.00 
   d 40   55.9   56.8   0.66    2.00 
   d 55  58.9   60.3   0.50    2.00 
   d 70  62.2   63.9   0.40    2.00 
Backfat, mm            
   d 0  15.0   15.2   0.83    0.95 
   d 40   16.3   17.9   0.10    0.95 
   d 55  16.7   17.2   0.60    0.95 
   d 70  15.9   15.4   0.60    0.95 
Estimated fat mass, lbc            
   d 0  60.2   60.2   0.99    2.86 
   d 40   68.7   72.9   0.16    2.86 
   d 55  73.2   76.0   0.34    2.86 
   d 70  75.9   77.4   0.61    2.86 
             
  Trt Day of Sample Trt × Day of Sample     
Weight, lb  0.58 <0.0001 0.11      
Estimated protein mass, lb 0.64 <0.0001 0.20      
Backfat, mm  0.30 0.0023 0.35      
Estimated fat mass, lb 0.44 <0.0001 0.10      
ad 0 to 70.   
bPrediction equation from Dourmad et al. (1997), 2.28 + 0.178 (liveweight, lb) – 0.333 × (backfat, mm). 
cPrediction equation from Dourmad et al. (1997), -26.40 + 0.221 × (liveweight, lb) + 1.331 × (backfat, 
mm). 
 
